https://scholars.lib.ntu.edu.tw/handle/123456789/634649
Title: | Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis | Authors: | Liam, Chong Kin Ahmad, Azura Rozila Hsia, Te-Chun Zhou, Jianying Kim, Dong-Wan Soo, Ross Andrew Cheng, Ying Lu, Shun Shin, Sang Won CHIH-HSIN YANG Zhang, Yiping Zhao, Jun Berghoff, Karin Bruns, Rolf Johne, Andreas Wu, Yi-Long |
Issue Date: | 15-May-2023 | Journal Volume: | 29 | Journal Issue: | 10 | Source: | Clinical cancer research : an official journal of the American Association for Cancer Research | Abstract: | The final analyses of the INSIGHT phase II study evaluating tepotinib (a selective MET inhibitor) plus gefitinib versus chemotherapy in patients with MET-altered EGFR-mutant NSCLC (data cut-off: September 3, 2021). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/634649 | ISSN: | 10780432 | DOI: | 10.1158/1078-0432.CCR-22-3318 |
Appears in Collections: | 醫學院附設癌醫中心醫院(臺大癌醫) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.